Extracellular L‐arginine is required for optimal NO synthesis by eNOS and iNOS in the rat mesenteric artery wall
The formation of NO from endothelial nitric oxide synthase (eNOS) in rat superior mesenteric artery rings was dependent on extracellular L‐arginine, and was optimal at a concentration of L‐arginine close to the plasma level (carbachol‐stimulated NO: control 15.7±0.9, L‐arginine 100 μM 22.8±1.3 nM)....
Gespeichert in:
Veröffentlicht in: | British journal of pharmacology 2003-08, Vol.139 (8), p.1487-1497 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1497 |
---|---|
container_issue | 8 |
container_start_page | 1487 |
container_title | British journal of pharmacology |
container_volume | 139 |
creator | MacKenzie, Andrew Wadsworth, Roger M |
description | The formation of NO from endothelial nitric oxide synthase (eNOS) in rat superior mesenteric artery rings was dependent on extracellular L‐arginine, and was optimal at a concentration of L‐arginine close to the plasma level (carbachol‐stimulated NO: control 15.7±0.9, L‐arginine 100 μM 22.8±1.3 nM).
Enhancement of NO output by L‐arginine was stereospecific, required the cationic amino‐acid transporter and was dependent on caveolin.
Induction of inducible nitric oxide synthase (iNOS) impaired the stimulated NO synthesis from eNOS (100 nM carbachol‐stimulated NO: control 5.7±0.6, iNOS 0.3±0.3 nM).
The interaction between iNOS and eNOS was reversed by the superoxide scavenger MnTMPyP. Impairment of eNOS by iNOS was also prevented by L‐arginine 100 μM administered simultaneously with carbachol, but not by L‐arginine administered during incubation with lipopolysaccharide.
These data provide functional evidence that supplementing L‐arginine from the extracellular medium optimises the formation of NO from eNOS and suggests that the impairment of eNOS by iNOS is caused by excess formation of superoxide by NO synthase, which can be prevented by L‐arginine. These results provide an explanation for the observations that extracellular L‐arginine can enhance endothelium function only when the endothelium is impaired or when iNOS has been induced.
British Journal of Pharmacology (2003) 139, 1487–1497. doi:10.1038/sj.bjp.0705380 |
doi_str_mv | 10.1038/sj.bjp.0705380 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1573978</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73555184</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4871-270692d98c9dc76aee379998bf1c7ece9dbc2b8f8dbc7bfd8278495e0c8515e43</originalsourceid><addsrcrecordid>eNqFkcFu1DAQhi0EokvhyhFZSHDLYsdxbF-QoCoUadVFAs6W40xaR15nayeU3HgEnpEnwauNKHDhNCPNNzP_zI_QU0rWlDD5KvXrpt-viSCcSXIPrWgl6iLn9D5aEUJEQamUJ-hRSj0huSj4Q3RCS1WWitUrFM-_jdFY8H7yJuLNz-8_TLxywQXALuEIN5OL0OJuiHjYj25nPL7c4jSH8RpSJpoZw-X2Ezahxe6QuIBzCUcz4h0kCCNEZ7GJOc741nj_GD3ojE_wZImn6Mu7889nF8Vm-_7D2ZtNYSspaFEKUquyVdKq1oraADChlJJNR60AC6ptbNnITuYomq6VpZCV4kCs5JRDxU7R6-Pc_dTsoLVZSjRe72M-Is56ME7_XQnuWl8NXzXlgikh84CXy4A43EyQRr1z6fAqE2CYkhaMc07lYdPzf8B-mGLIx-mSCqooV3WG1kfIxiGlCN1vJZTog5c69Tp7qRcvc8OzP_Xf4Yt5GXixACZZ47tognXpjuNE5EeyzLEjd-s8zP9Zq99-vOC0ouwXvw67IQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>217191596</pqid></control><display><type>article</type><title>Extracellular L‐arginine is required for optimal NO synthesis by eNOS and iNOS in the rat mesenteric artery wall</title><source>Wiley Free Content</source><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>MacKenzie, Andrew ; Wadsworth, Roger M</creator><creatorcontrib>MacKenzie, Andrew ; Wadsworth, Roger M</creatorcontrib><description>The formation of NO from endothelial nitric oxide synthase (eNOS) in rat superior mesenteric artery rings was dependent on extracellular L‐arginine, and was optimal at a concentration of L‐arginine close to the plasma level (carbachol‐stimulated NO: control 15.7±0.9, L‐arginine 100 μM 22.8±1.3 nM).
Enhancement of NO output by L‐arginine was stereospecific, required the cationic amino‐acid transporter and was dependent on caveolin.
Induction of inducible nitric oxide synthase (iNOS) impaired the stimulated NO synthesis from eNOS (100 nM carbachol‐stimulated NO: control 5.7±0.6, iNOS 0.3±0.3 nM).
The interaction between iNOS and eNOS was reversed by the superoxide scavenger MnTMPyP. Impairment of eNOS by iNOS was also prevented by L‐arginine 100 μM administered simultaneously with carbachol, but not by L‐arginine administered during incubation with lipopolysaccharide.
These data provide functional evidence that supplementing L‐arginine from the extracellular medium optimises the formation of NO from eNOS and suggests that the impairment of eNOS by iNOS is caused by excess formation of superoxide by NO synthase, which can be prevented by L‐arginine. These results provide an explanation for the observations that extracellular L‐arginine can enhance endothelium function only when the endothelium is impaired or when iNOS has been induced.
British Journal of Pharmacology (2003) 139, 1487–1497. doi:10.1038/sj.bjp.0705380</description><identifier>ISSN: 0007-1188</identifier><identifier>EISSN: 1476-5381</identifier><identifier>DOI: 10.1038/sj.bjp.0705380</identifier><identifier>PMID: 12922936</identifier><identifier>CODEN: BJPCBM</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Animals ; Arginine - pharmacology ; Biological and medical sciences ; Carbachol - pharmacology ; Caveolin 1 ; Caveolins - pharmacology ; Enzyme Induction ; In Vitro Techniques ; iNOS ; Lipopolysaccharides - pharmacology ; L‐arginine ; Male ; Medical sciences ; Mesenteric Arteries - drug effects ; Mesenteric Arteries - enzymology ; Mesenteric Arteries - metabolism ; Metalloporphyrins - pharmacology ; Nitric oxide ; Nitric Oxide - biosynthesis ; Nitric Oxide Synthase - biosynthesis ; Nitric Oxide Synthase Type II ; Nitric Oxide Synthase Type III ; Pharmacology. Drug treatments ; Rats ; Rats, Sprague-Dawley ; Superoxide Dismutase - metabolism</subject><ispartof>British journal of pharmacology, 2003-08, Vol.139 (8), p.1487-1497</ispartof><rights>2003 British Pharmacological Society</rights><rights>2004 INIST-CNRS</rights><rights>Copyright Nature Publishing Group Aug 2, 2003</rights><rights>Copyright 2003, Nature Publishing Group 2003 Nature Publishing Group</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4871-270692d98c9dc76aee379998bf1c7ece9dbc2b8f8dbc7bfd8278495e0c8515e43</citedby><cites>FETCH-LOGICAL-c4871-270692d98c9dc76aee379998bf1c7ece9dbc2b8f8dbc7bfd8278495e0c8515e43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1573978/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1573978/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,1411,1427,27903,27904,45553,45554,46387,46811,53769,53771</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15078713$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12922936$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MacKenzie, Andrew</creatorcontrib><creatorcontrib>Wadsworth, Roger M</creatorcontrib><title>Extracellular L‐arginine is required for optimal NO synthesis by eNOS and iNOS in the rat mesenteric artery wall</title><title>British journal of pharmacology</title><addtitle>Br J Pharmacol</addtitle><description>The formation of NO from endothelial nitric oxide synthase (eNOS) in rat superior mesenteric artery rings was dependent on extracellular L‐arginine, and was optimal at a concentration of L‐arginine close to the plasma level (carbachol‐stimulated NO: control 15.7±0.9, L‐arginine 100 μM 22.8±1.3 nM).
Enhancement of NO output by L‐arginine was stereospecific, required the cationic amino‐acid transporter and was dependent on caveolin.
Induction of inducible nitric oxide synthase (iNOS) impaired the stimulated NO synthesis from eNOS (100 nM carbachol‐stimulated NO: control 5.7±0.6, iNOS 0.3±0.3 nM).
The interaction between iNOS and eNOS was reversed by the superoxide scavenger MnTMPyP. Impairment of eNOS by iNOS was also prevented by L‐arginine 100 μM administered simultaneously with carbachol, but not by L‐arginine administered during incubation with lipopolysaccharide.
These data provide functional evidence that supplementing L‐arginine from the extracellular medium optimises the formation of NO from eNOS and suggests that the impairment of eNOS by iNOS is caused by excess formation of superoxide by NO synthase, which can be prevented by L‐arginine. These results provide an explanation for the observations that extracellular L‐arginine can enhance endothelium function only when the endothelium is impaired or when iNOS has been induced.
British Journal of Pharmacology (2003) 139, 1487–1497. doi:10.1038/sj.bjp.0705380</description><subject>Animals</subject><subject>Arginine - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Carbachol - pharmacology</subject><subject>Caveolin 1</subject><subject>Caveolins - pharmacology</subject><subject>Enzyme Induction</subject><subject>In Vitro Techniques</subject><subject>iNOS</subject><subject>Lipopolysaccharides - pharmacology</subject><subject>L‐arginine</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mesenteric Arteries - drug effects</subject><subject>Mesenteric Arteries - enzymology</subject><subject>Mesenteric Arteries - metabolism</subject><subject>Metalloporphyrins - pharmacology</subject><subject>Nitric oxide</subject><subject>Nitric Oxide - biosynthesis</subject><subject>Nitric Oxide Synthase - biosynthesis</subject><subject>Nitric Oxide Synthase Type II</subject><subject>Nitric Oxide Synthase Type III</subject><subject>Pharmacology. Drug treatments</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Superoxide Dismutase - metabolism</subject><issn>0007-1188</issn><issn>1476-5381</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkcFu1DAQhi0EokvhyhFZSHDLYsdxbF-QoCoUadVFAs6W40xaR15nayeU3HgEnpEnwauNKHDhNCPNNzP_zI_QU0rWlDD5KvXrpt-viSCcSXIPrWgl6iLn9D5aEUJEQamUJ-hRSj0huSj4Q3RCS1WWitUrFM-_jdFY8H7yJuLNz-8_TLxywQXALuEIN5OL0OJuiHjYj25nPL7c4jSH8RpSJpoZw-X2Ezahxe6QuIBzCUcz4h0kCCNEZ7GJOc741nj_GD3ojE_wZImn6Mu7889nF8Vm-_7D2ZtNYSspaFEKUquyVdKq1oraADChlJJNR60AC6ptbNnITuYomq6VpZCV4kCs5JRDxU7R6-Pc_dTsoLVZSjRe72M-Is56ME7_XQnuWl8NXzXlgikh84CXy4A43EyQRr1z6fAqE2CYkhaMc07lYdPzf8B-mGLIx-mSCqooV3WG1kfIxiGlCN1vJZTog5c69Tp7qRcvc8OzP_Xf4Yt5GXixACZZ47tognXpjuNE5EeyzLEjd-s8zP9Zq99-vOC0ouwXvw67IQ</recordid><startdate>200308</startdate><enddate>200308</enddate><creator>MacKenzie, Andrew</creator><creator>Wadsworth, Roger M</creator><general>Blackwell Publishing Ltd</general><general>Nature Publishing</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>200308</creationdate><title>Extracellular L‐arginine is required for optimal NO synthesis by eNOS and iNOS in the rat mesenteric artery wall</title><author>MacKenzie, Andrew ; Wadsworth, Roger M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4871-270692d98c9dc76aee379998bf1c7ece9dbc2b8f8dbc7bfd8278495e0c8515e43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Animals</topic><topic>Arginine - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Carbachol - pharmacology</topic><topic>Caveolin 1</topic><topic>Caveolins - pharmacology</topic><topic>Enzyme Induction</topic><topic>In Vitro Techniques</topic><topic>iNOS</topic><topic>Lipopolysaccharides - pharmacology</topic><topic>L‐arginine</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mesenteric Arteries - drug effects</topic><topic>Mesenteric Arteries - enzymology</topic><topic>Mesenteric Arteries - metabolism</topic><topic>Metalloporphyrins - pharmacology</topic><topic>Nitric oxide</topic><topic>Nitric Oxide - biosynthesis</topic><topic>Nitric Oxide Synthase - biosynthesis</topic><topic>Nitric Oxide Synthase Type II</topic><topic>Nitric Oxide Synthase Type III</topic><topic>Pharmacology. Drug treatments</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Superoxide Dismutase - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MacKenzie, Andrew</creatorcontrib><creatorcontrib>Wadsworth, Roger M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MacKenzie, Andrew</au><au>Wadsworth, Roger M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Extracellular L‐arginine is required for optimal NO synthesis by eNOS and iNOS in the rat mesenteric artery wall</atitle><jtitle>British journal of pharmacology</jtitle><addtitle>Br J Pharmacol</addtitle><date>2003-08</date><risdate>2003</risdate><volume>139</volume><issue>8</issue><spage>1487</spage><epage>1497</epage><pages>1487-1497</pages><issn>0007-1188</issn><eissn>1476-5381</eissn><coden>BJPCBM</coden><abstract>The formation of NO from endothelial nitric oxide synthase (eNOS) in rat superior mesenteric artery rings was dependent on extracellular L‐arginine, and was optimal at a concentration of L‐arginine close to the plasma level (carbachol‐stimulated NO: control 15.7±0.9, L‐arginine 100 μM 22.8±1.3 nM).
Enhancement of NO output by L‐arginine was stereospecific, required the cationic amino‐acid transporter and was dependent on caveolin.
Induction of inducible nitric oxide synthase (iNOS) impaired the stimulated NO synthesis from eNOS (100 nM carbachol‐stimulated NO: control 5.7±0.6, iNOS 0.3±0.3 nM).
The interaction between iNOS and eNOS was reversed by the superoxide scavenger MnTMPyP. Impairment of eNOS by iNOS was also prevented by L‐arginine 100 μM administered simultaneously with carbachol, but not by L‐arginine administered during incubation with lipopolysaccharide.
These data provide functional evidence that supplementing L‐arginine from the extracellular medium optimises the formation of NO from eNOS and suggests that the impairment of eNOS by iNOS is caused by excess formation of superoxide by NO synthase, which can be prevented by L‐arginine. These results provide an explanation for the observations that extracellular L‐arginine can enhance endothelium function only when the endothelium is impaired or when iNOS has been induced.
British Journal of Pharmacology (2003) 139, 1487–1497. doi:10.1038/sj.bjp.0705380</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>12922936</pmid><doi>10.1038/sj.bjp.0705380</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0007-1188 |
ispartof | British journal of pharmacology, 2003-08, Vol.139 (8), p.1487-1497 |
issn | 0007-1188 1476-5381 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1573978 |
source | Wiley Free Content; MEDLINE; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection |
subjects | Animals Arginine - pharmacology Biological and medical sciences Carbachol - pharmacology Caveolin 1 Caveolins - pharmacology Enzyme Induction In Vitro Techniques iNOS Lipopolysaccharides - pharmacology L‐arginine Male Medical sciences Mesenteric Arteries - drug effects Mesenteric Arteries - enzymology Mesenteric Arteries - metabolism Metalloporphyrins - pharmacology Nitric oxide Nitric Oxide - biosynthesis Nitric Oxide Synthase - biosynthesis Nitric Oxide Synthase Type II Nitric Oxide Synthase Type III Pharmacology. Drug treatments Rats Rats, Sprague-Dawley Superoxide Dismutase - metabolism |
title | Extracellular L‐arginine is required for optimal NO synthesis by eNOS and iNOS in the rat mesenteric artery wall |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T18%3A50%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Extracellular%20L%E2%80%90arginine%20is%20required%20for%20optimal%20NO%20synthesis%20by%20eNOS%20and%20iNOS%20in%20the%20rat%20mesenteric%20artery%20wall&rft.jtitle=British%20journal%20of%20pharmacology&rft.au=MacKenzie,%20Andrew&rft.date=2003-08&rft.volume=139&rft.issue=8&rft.spage=1487&rft.epage=1497&rft.pages=1487-1497&rft.issn=0007-1188&rft.eissn=1476-5381&rft.coden=BJPCBM&rft_id=info:doi/10.1038/sj.bjp.0705380&rft_dat=%3Cproquest_pubme%3E73555184%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=217191596&rft_id=info:pmid/12922936&rfr_iscdi=true |